HDAC6 and ovarian carcinoma: In ovarian cancer and hepatocellular carcinoma, high HDAC6 is associated with advanced clinical stage, higher number of tumours, vascular and intrahepatic invasion, and metastasis, which are related to poor prognosis, respectively [31].